Arcus Biosciences RCUS
NYSE RCUS
$25.85 +0.19 (+0.74%)
At close: Sep 30, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Updated

Arcus Biosciences' Tax Provisions was $1 million in Q4 2024, unchanged from $1 million a year earlier.

Analysis

Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024) Analysis & Trends

From Q4 2021 onward, Arcus Biosciences has reported Tax Provisions for 7 quarters.

  • Tax Provisions shows a three-year compound annual growth rate of -20.6% (FY2021 to FY2024).
  • In earlier years, Tax Provisions was $6 million in FY2023 (+500.0%), $1 million in FY2022 (-50.0%) and $2 million in FY2021.
  • Quarterly Tax Provisions has moved between $1 million (Q1 2022) and $2 million (Q3 2023) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Arcus Biosciences 3.28 Bn -53.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.00 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 2.00 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 2.00 Mn
API Access

Arcus Biosciences Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=RCUS&period=max&api_key=YOUR_API_KEY